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In calves,  passive  immunity  of immunoglobulins  can be acquired  through  ingestion  of
colostrum  or  colostrum  replacers.  Plasma  can  been  used  to supplement  immunoglobulins
in healthy  or  sick  calves.  Serum  half-life  of  colostral  derived  immuglobulin  G  (IgG)  is  esti-
mated  to be 20  days.  Half-life  of IgG  is  important  in  determining  response  to antigens  and
timing  of vaccination  in calves.  To  date  studies  evaluating  half-life  of  colostrum  replacer  or
plasma  derived  IgG are  lacking.  The  objectives  of this  study  were  to compare  the  serum  half-
life of  IgG  derived  from  colostrum,  colostrum  replacer  and  plasma  in dairy  calves  reared
up to  35  days  of age.  Thirty  Jersey  calves  were  randomly  assigned  to receive  colostrum
or  colostrum  replacer  by  oroesophageal  tubing  or plasma  by intravenous  administration.
Serum  samples  were  collected  at 2, 5, 7, 10,  14, 21,  28  and  35  days.  Serum  IgG  concen-mmunoglobulin trations  were  determined  by radial immunodiffusion.  The  results  indicated  that half-life
for  IgG  in  colostrum  fed  (28.5  days)  or  plasma  transfused  calves  (27.3  days)  was  longer
than  colostrum  replacer  fed  calves  (19.1  days).  Further  studies  are  required  to  evaluate
pathogen specific  immunoglobulins  in  order  to  recommend  vaccination  timing  in  calves
fed colostrum  replacers.. Introduction
The cotyledonary type placenta restricts transfer of
mmunoglobulins from cow to the fetus during pregnancy
Arthur, 1999). Consequently calves are born hypogam-
aglobulinemic, thus making it essential for calves to
ngest and absorb colostral immunoglobulins to acquire
assive immunity. Half of all neonatal mortality can be
irectly attributed to failure to acquire passive immu-
ity at birth (Tyler et al., 1999). Acquiring of passive
mmunity through ingestion and absorption of colostral
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immunoglobulins at birth in calves can be achieved by feed-
ing colostrum or colostrum replacers. Colostrum replacers
are used on dairy farms when sufficient colostrum is not
available or to prevent transmission of diseases that can
be transmitted through unpasteurized colostrum (Foster
et al., 2006). In veterinary clinical settings, plasma has
been used to supplement immunoglobulins in clinically
healthy or sick neonatal calves with or without ade-
quate ingestion of colostral immunoglobulins (Selim et al.,
1995).
Colostral derived immunoglobulins can suppress
neonatal immunity by various mechanisms (Banks, 1982).
Previous studies demonstrated that colostrum deprived
calves produced IgG and IgA earlier than colostrum fed
calves (Husband and Lascelles, 1975). The mechanism
of suppression of the immune system by the colostral-
derived immunoglobulins can be either antigen specific
ogy and 234 J.M. Murphy et al. / Veterinary Immunol
or non-antigen specific (Banks, 1982). As a result of this
immune system suppression, concentrations of colostral
derived maternal immunoglobulins must be reduced to
a critical low level that does not interfere with response
to antigen exposure or vaccination (Pastoret, 2007). The
rate at which this critical low level of immunoglobulins
is achieved is dependent on the immunoglobulin con-
centration and immunoglobulin class absorbed at birth
because each class of immunoglobulin is catabolized at
a different rate. The half-life of each immunoglobulin
can be used to estimate the rate of its catabolism. The
serum half-life of colostral-derived immuglobulin G (IgG),
M (IgM), and A (IgA) in calves was 20, 4.8, and 2.8 days,
respectively (Banks, 1982). In cattle, the predominant
colostral immunoglobulin (85–90%) is IgG while IgM
and IgA constitute approximately 7% and 3% respectively
(Larson et al., 1979).
To the best of authors’ knowledge, no studies have eval-
uated the half-life of colostrum replacer or plasma derived
IgG in dairy calves. We  hypothesized that the half-life of
maternally derived colostral IgG will have a significantly
longer half-life compared to colostrum replacer or plasma
derived IgG. The objective of this study was to compare the
serum half-life of IgG derived from colostrum, colostrum
replacer and plasma in dairy calves reared up to 35 days of
age. The results of the study were intended to evaluate if
different timing of vaccination should be considered when
vaccinating colostrum fed calves as opposed to colostrum
replacer fed dairy calves or plasma transfused calves. Addi-
tionally, information on serum half-life of plasma-derived
IgG would help predict when to repeat plasma transfusion
in clinical settings.
2. Materials and methods
2.1. Animals and sampling procedures
The study was approved by the University of California,
Davis (UC Davis) Institutional Animal Care and Use Pro-
tocol (Protocol Number 17630). Sample size calculation
was based on a 50% mortality rate attributed to calves not
ingesting sufficient colostrum (Tyler et al., 1999), alpha of
5%, power of 80% and a mortality rate of up to 13% during
the first 4 weeks of life in calves failing to ingest sufficient
colostrum at birth, in California (Moore et al., 2002). The
total sample size required was 27 calves. In order to account
for a 10% dropout due to missed sampling, 30 calves were
enrolled.
All calves were enrolled from a single Jersey dairy farm
in Hilmar, California (Merced County). Adult cows on the
farm of study were vaccinated annually with a multiva-
lent modified live respiratory vaccine containing infectious
bovine rhinotracheitis,  bovine viral diarrhea, parainfluenza-
3 and bovine respiratory syncytial viruses and dewormed
twice a year with topical ivermectin. Additionally, the cows
were vaccinated with a multivalent vaccine containing
Escherichia coli, rotavirus and coronavirus during the dry
cow period.
Thirty Jersey bull calves delivered from eutocia and
observed births were immediately separated from the
dam following parturition. The calves were identifiedImmunopathology 158 (2014) 233–237
using plastic ear tags and weighed. Calves were ran-
domly assigned to receive pooled, pasteurized colostrum
from the farm of study or colostrum replacer (The Saska-
toon Colostrum Co, Saskatoon, Canada) or bovine plasma
(Transfusion Services, University of California, Davis, CA).
Colostrum was pasteurized using a batch pasteurizer at
60◦ C for 30 min  with continuous agitation followed by
cooling at 4◦ C. All calves received colostrum or colostrum
replacer or bovine plasma within 2 h after birth. The bovine
plasma was  derived from 2 clinically healthy, UC Davis
Veterinary Medical Teaching Hospital blood donor cows.
The plasma was  evaluated for sterility and considered
to be free of transmissible blood borne pathogens. The
plasma from the 2 blood donor cows was  not pooled.
Serum samples were collected from all calves prior to any
procedure for subsequent serum IgG determination. An
aliquot (5 ml)  of colostrum or plasma to be administered
was  collected prior to administration for subsequent IgG
concentration determination. No samples were collected
from the colostrum replacer because the IgG concentra-
tion was  known according to the manufacturer’s label.
All calves were enrolled into the study over a 2-week
period.
Calves in the colostrum (CL, control group) group were
fed 3 L of colostrum once by oroesophageal tubing. Calves in
the colostrum replacer (CR) group were fed 2.5 L (2 bags) of
colostrum replacer, once, according to the manufacturer’s
recommendations delivering 200 g of IgG for absorption by
oroesophageal tubing. Calves in the plasma (PL) group were
administered with bovine plasma at 30 ml/kg (Barrington
and Parish, 2009) through an intravenous catheter (Becton
and Dickinson Co, Franklin Lakes, NJ) aseptically placed in
the external jugular vein. Infusion of plasma was  performed
slowly (10 ml/kg/h) over the first 20 min. Monitoring for
transfusion reactions included monitoring heart rate, respi-
ratory rate, color of mucous membranes, and abnormal
behavior. In the absence of an immediate transfusion reac-
tion, the remainder of the plasma was transfused over
20–30 min. In the presence of a plasma transfusion reac-
tion, transfusion was discontinued for 10 min  and resumed
at 5 ml/kg/h.
The calves were then housed in individual plastic calf
hutches at the UC Davis Beef Research facilities. Calves were
fed 2 L of non-medicated milk replacer (Calva Products,
Acampo, CA) and 0.5 kg of commercial calf concentrate
(Department of Animal Science, University of California,
Davis, CA) twice daily. At 4 weeks of age, calves were fed
3 L of milk replacer and 1 kg of commercial calf concentrate,
twice daily. Serum samples were collected at 2, 5, 7, 10, 14,
21, 28 and 35 days of age. All calves were weighed at the end
of the study (5 weeks of age). Samples of serum collected
at different time points, colostrum, and plasma adminis-
tered were stored at −20◦ C until serum IgG determination.
Calves were monitored for health by daily evaluation of
appetite, rectal temperature, signs of coughing, diarrhea
and lameness. Sick calves were treated following recom-
mendations by a UC Davis licensed veterinarian as per the
UC Davis Institutional Animal Care and Use Protocol. Calves
that died were submitted for a complete necropsy at the
California Animal Health and Food Safety Laboratory in
Davis, CA.
ogy and 
d
(
(
c
p
r
a
r
v
p
(
(
i
r
t
R
2
d
c
s
(
t
1
c
c
2
t
t
w
I
a
i
c
e
t
a
<
i
f
2
p
l
p
u
 IgG in
w
P
c
t
p
a
p
wJ.M. Murphy et al. / Veterinary Immunol
Serum, plasma or colostral IgG concentrations were
etermined using a commercial radial immunodiffusion
RID) kit based on the manufacturer’s recommendations
Triple J Farms, Bellingham, WA). Briefly, RID plates
ontaining specific anti-bovine IgG, agarose gel, 0.1 M
hosphate buffer pH 7.0, 0.1% sodium azide as a bacte-
iostatic agent and 1 g/ml amphotericin B as a fungal
gent stored in a refrigerator at 4◦ C were warmed at
oom temperature (20–24◦ C). An aliquot (5 l) of the pro-
ided reference serum at 3 different concentrations were
ipetted into each RID wells. An aliquot (5 l) of serum
diluted 1:2 with phosphate buffer) or colostrum samples
diluted 1:4 with phosphate buffer) were pipetted into
ndividual RID plate wells. The plates were incubated at
oom temperature (20–24◦ C) for 24 h. The diameters of
he zones of precipitation were measured using a digital
ID plate reader (The Binding Site Inc, San Diego, CA) after
4 h. Serum or colostral sample IgG concentrations were
etermined by comparing the diameter of the zones of pre-
ipitation with a standard curve generated by the reference
erum. The regression equation generated in this manner
r2 = 0.97–0.99) accurately predicts inoculum IgG concen-
ration. Minimum detectable serum IgG concentration was
96 mg/dL using the RID. For the purposes of this study,
alves determined to have <196 mg/dL of IgG by RID were
onsidered to have 195 mg/dL IgG.
.2. Statistical analysis
Normality of data was checked using the Shapiro–Wilk
est. In instances where the data was not normally dis-
ributed, the median was reported. Descriptive statistics
ere calculated for calf birth weight, 5-week weight, serum
gG concentrations at 2 days, IgG concentrations in plasma
dministered and colostral IgG concentrations, morbid-
ty and mortality events among the 3 groups. Serum IgG
oncentrations at 2 days were used to compare the pres-
nce of failure of passive transfer of immunity among
he groups using a Kruskal–Wallis, 1-way analysis of vari-
nce on ranks. Calves with serum IgG concentrations of
1000 mg/dL were considered to have failure of passive
mmunity (Besser et al., 1991). Proportions of calves with
ailure of passive transfer of colostral immunoglobulins at
 days or calves that died among the 3 groups were com-
ared using a 2 test or Fisher’s exact test when a cell had
ess than 5 counts.
In calves that received plasma transfusion, the predicted
ost-transfusion serum IgG concentration was calculated
sing the following formula (Chigerwe and Tyler, 2010):
(Weight × 0.0971 L plasma/kg × IgG) ± (plasma volume ×
Weight × 0.0971 L
here weight = mean weight (kg) of the calves in the
L group; 0.097 L plasma/kg = plasma volume in Jersey
alves (Quigley et al., 1998); IgG = serum IgG concentra-
ion (mg/dL) prior to administration of plasma; IgG in
lasma = mean IgG concentration (mg/dL) in the plasma
dministered; and plasma volume = mean volume (L) of
lasma administered IV at 30 ml/kg.
Serum half-life for IgG in each of the 3 groups of calves
as determined by a non-linear regression analysis usingImmunopathology 158 (2014) 233–237 235
 plasma)
(1)
a one-phase exponential decay model with random effects
for calf initial serum IgG concentrations. The decay of IgG
over time was  assumed to be constant. Differences in serum
IgG half-life among the 3 groups were evaluated by com-
paring the rate constants using an F-test. In all statistical
analyses values of P < 0.05 were considered significant. All
statistical analyses were performed using a commercial
statistical software (Prism 6, GraphPad Inc, La Jolla, CA).
3. Results and discussion
Mean ± SD birth weight for all 30 calves was
27.6 ± 3.5 kg. Mean ± SD birth weight for the CL, CR
and PL group was 30 ± 2.9, 27.8 ± 2.3 and 25.1 ± 3.6 kg,
respectively. All calves had a serum IgG concentration
of <196 mg/dL prior to feeding colostrum or colostrum
replacer or administration of plasma. Mean colostral IgG
concentration fed to the CL group was 66.1 g/L. Mean
plasma volume and mean plasma IgG concentrations
administered to the calves in the PL group were 753 ml
and 2848.4 mg/dL, respectively. None of the calves in
the PL group showed immediate transfusion reactions.
All calves in the CL and CR group had adequate transfer
of immunity (serum IgG concentrations >1000 mg/dL at
2 days of age). Median (interquartile range) serum IgG
concentrations at 2 days of age for calves in the CL, CR
and PL groups were 2377.5 (421.9), 2306 (475.2), and
669.3 (267.8), respectively. Only 1 calf in the PL group
had serum IgG concentrations >1000 mg/dL. There was no
difference in median serum IgG concentrations at 2 days
between calves in the CL and CR groups (P = 0.565). Median
serum IgG concentrations of calves in the PL group were
lower than calves in both CL (P < 0.001) and CR (P < 0.001)
groups. Using Eq. (1) and substituting for a mean weight
of 25.1 kg, serum IgG concentration of 195 mg/dL prior
to administration of plasma, mean plasma volume of
753 ml  (25.1 kg × 30 ml/kg) administered, mean plasma
IgG concentration of 2848.4 mg/kg, the expected serum
IgG concentration at 2 days of age in the PL group was
1074.9 mg/dL.
Morbidity events were recorded in 21 calves (70% with
20 diarrhea cases and 1 pneumonia case). Fourteen of the
21 morbidity cases in the calves required treatment with
antibiotics and or oral rehydration electrolyte solutions. Six
calves died during the 5-week period. Of the calves that
died or were euthanized, 4 calves were from the PL group,
1 from the CL group and 1 from the CR group. Mortality in
the 6 calves occurred during the first 12 days of life. Causes
of mortality in the 6 calves included enteritis secondary to
enterotoxigenic E. coli, rotavirus and Cryptosporidium in 4
calves, enterocolitis due to Clostridium perfringens in 1 calf
and enterocolitis due to E. coli, rotavirus and bovine viral
diarrhea virus (BVDV) in 1 calf. Given that 1 calf tested
positive for BVDV on necropsy, all remaining calves (24
calves) calves were tested for BVDV by immunohistochem-
istry on ear notch skin biopsy. All remaining calves tested
negative for BVDV. Proportions of calves with failure of
236 J.M. Murphy et al. / Veterinary Immunology and Immunopathology 158 (2014) 233–237
Table 1
Summary of descriptive statistics for calves fed colostrum or colostrum replacer or intravenous transfusion with bovine plasma (N = 30).
All calves Colostrum group
(CL)
Colostrum replacer
group (CR)
Plasma group
(PL)
Birth weight (kg) 26 ± 3.5 30 ± 2.9a 27.8 ± 2.3a 25.1 ± 3.6a
Mean colostrum IgG fed or transfused 66 200 2848.4
Median serum IgG concentration at 2
days (mg/dL)
2377.5 (421.9)a 2306 (475.2)a 669.3 (267.8)b
Mortality (%) 20 10a 10a 40b
IgG half-life (days) 28.5 (23.4, 36.5)a 19.1 (15.7, 24.5)b 27.3 (16.6,
75.6)a
Birth weight was  reported as mean ± SD. Mean colostrum IgG fed to the CR group was reported as g/L and grams of IgG in the CR group. Mean IgG
concentrations transfused to the PL group was reported as mg/dL. Median serum IgG concentration was reported as median (interquartile range). Half-life
of  IgG was reported as days (95% CI).
 row areWhere applicable, values with the same letter superscript within a given
passive transfer between the CL and CR groups were not
different (P = 1). Proportions of calves that died in the PL
group were higher compared with the CL (P < 0.001) and
CR (P < 0.001) groups. Mean ± SD weight for the remaining
24 calves at 5 weeks was 38.9 ± 9.3 kg with a daily average
gain of 0.4 kg/day.
Half-life (95% confidence interval) for colostral, plasma
and colostrum replacer derived IgG was 28.5 (23.4, 36.5),
27.3 (16.6, 75.6) and 19.1 (15.7, 24.5) days, respectively.
The half-life for the CL and PL was not different (P = 0.420).
The half-life for the CL (P < 0.001) and PL (P < 0.001) groups
was longer than that of the CR group. Summarized descrip-
tive statistics results are represented in Table 1. The decay
curves generated for the 3 groups of calves are represented
in Fig. 1.
The aim of this study was to compare serum half-life
of IgG derived from colostrum or colostrum replacer and
plasma. The main finding in this study demonstrated that
half-life of colostral derived IgG was longer than colostrum
replacer derived IgG. Although these study results sug-
gest different timing when vaccinating colostrum or
colostrum replacer fed dairy calves, the current studies
did not evaluate specific pathogen immunoglobulins to
common vaccinations in adult dairy cows and pre-weaned
dairy calves. The specific immunoglobulins for pathogens
to be considered in future studies include rotavirus,
coronavirus, infectious bovine rhinotracheitis,  bovine viral
diarrhea, parainfluenza-3 and bovine respiratory syncy-
tial viruses. While the specificity of the colostral-derived
Fig. 1. Fitted exponential decay curves over 35 days of serum IgG concen-
trations in calves that were fed colostrum or bovine colostrum replacer or
intravenously transfused with bovine plasma. not different (P > 0.05).
immunoglobulins is important to confer specific immunity,
it should be noted that at birth calves have greater num-
ber of neutrophils compared to adult cattle (Rossi et al.,
1979). Primary and secondary lymphoid tissues of newborn
calves are populated by immune cells and the circulatory
B-lymphocytes can synthesize immunoglobulins follow-
ing antigenic stimulation (Banks, 1982). Thus passively
acquired IgG are not the only immunoglobulins involved
during conference of immune protection after birth; but
cells from lymphoid tissues and neutrophils from circula-
tion are also involved. Therefore lack of specificity does not
necessarily result in occurrence of a morbidity event.
It is important to note that the half-life of colostral
derived IgG was  longer than previously reported in other
studies (Banks, 1982; Butler, 1983; Besser et al., 1988). Pre-
vious studies reported IgG half-life of 20 days (Banks, 1982),
17.9 days (Besser et al., 1988), 9.6 days for IgG1 (Butler,
1983) and 17.7 days for IgG2 (Butler, 1983) in calves. While
the age of the calves during determination of half-life was
not stated in two  of the studies (Banks, 1982; Butler, 1983),
serum collection in calves was  performed until 10 days of
age in the third study (Besser et al., 1988). We  chose to
determine serum IgG half-life in calves reared up to 35
days of age based on previous studies indicating that anti-
bodies to different bacterial and viral antigens were not
produced or did not appear in serum until 14–30 days of
age (Kerr, 1956; Lambert et al., 1969; Thorsen et al., 1969;
Husband and Lascelles, 1975). Thus, it can be assumed
that the majority of immunologlobulins in the serum are
colostral derived in calves aged up to 30 days. The differ-
ence in the duration of follow-up is a potential explanation
for the difference in the serum IgG half-life determinations
in the different studies.
Majority of calves in the PL group were anticipated to
achieve adequate transfer of immunoglobulins at 2 days
of age based on Eq. (1) and recommended plasma trans-
fusion rate, but only one calf achieved adequate transfer
of immunoglobulins. In contrast, the CL and CR group
achieved serum IgG consistent with adequate transfer of
immunity. One explanation for this observation is possi-
ble; increased catabolism due to complement activation by
IgG aggregates from the preparation process of the plasma
(Lundblad and Londeree, 1988). In contrast, absorption
of orally delivered IgG occurs within the first 24–36 h of
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irth is a non-selective passive process through pinocyto-
is (Stott et al., 1979). Thus, orally derived IgG may  undergo
atabolism through which intravenously derived IgG is
atabolized.
Intravenously derived immunoglobulins are re-
ecreted into the gastrointestinal tract and excreted
hrough the feces and urine (Besser et al., 1988). Fecal
r urinary IgG concentrations were not determined in
his study to evaluate rate of excretion among groups.
uture studies need to determine serum, fecal and urinary
gG concentrations in calves intravenously transfused
ith plasma at shorter intervals (for instance every 12 h)
rior to 48 h of age in order to evaluate the catabolism
f the immunoglobulins. Additionally, evaluation of
ctivity of IgG prior to and after plasma transfusion is
arranted.
The study design in this study differs from previ-
us studies (Besser et al., 1988; Jones et al., 2004) in
everal ways. In studies by Besser and others, calves
nly received variable volumes of colostrum followed
y 2.0 ml  of labeled sodium iodide intravenously with
o group of calves receiving colostrum replacer or
lasma. In studies by Jones and others fed colostrum
as twice to calves while the colostrum replacer was
ovine serum derived and the study design did not
nclude a group of calves administered intravenous
lasma.
It should be noted that in clinical practice, plasma is used
o supplement immunoglobulins and thus calves are more
ikely to have ingested insufficient or sufficient colostrum
n presentation. In this study, the PL group only received
lasma as the source of immunoglobulins. The results of
his study indicate that plasma products with sufficient
mmunoglobulins may  fail to achieve adequate immunity
hen administered in calves. Although the half-life of the
L was longer than the CR group, the 95% confidence for
he half-life estimate is very wide indicating that the esti-
ate is not precise. Thus it is difficult to recommend when
o repeat plasma transfusions in clinical settings based on
he results of this study.
ummary
The results of this study indicated that colostral derived
gG had a longer half-life compared to colostrum replacer
erived IgG. Future studies are required to evaluate
athogen specific immunoglobulins in order to recom-
end timing of vaccinations in calves fed colostrum
eplacer at birth. Administration of plasma to newborn
alves at the recommended dose did not achieve adequate
ransfer of immunoglobulins. Calves intravenously admin-
stered with plasma at birth were more likely to experience
ortality compared to calves that ingested colostrum or
olostrum replacer.onflict of interest
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